Centers of Educational Expertise
Express Scripts says AbbVie drug could displace Sovaldi on formulary
Humana CEO: New competition curbs Obamacare plan prices
FDA lifts partial hold on study testing myelofibrosis drug
EMA committee backs J&J hepatitis C pill plus new drugs from Lilly, Takeda
FDA approves drug for generalized lipodystrophy
FDA panel backs drug for generalized lipodystrophy
Drugs for HCV, HIV, diabetes recommended for approval in EU
FDA approves oral simeprevir (Olysio) for hepatitis C
Board of Trustees
Board of Advisors
Liver News Library
Hep C Link to Care
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation